Cibc World Markets Corp purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,006 shares of the medical instruments supplier's stock, valued at approximately $311,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in ICUI. Point72 Hong Kong Ltd bought a new stake in ICU Medical during the 3rd quarter valued at approximately $72,000. Venturi Wealth Management LLC grew its stake in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after purchasing an additional 567 shares during the last quarter. Coldstream Capital Management Inc. bought a new stake in ICU Medical in the 3rd quarter valued at $227,000. Finally, EP Wealth Advisors LLC acquired a new stake in ICU Medical in the 3rd quarter worth $247,000. 96.10% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms recently weighed in on ICUI. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Tuesday, March 18th. Raymond James set a $97.00 price objective on ICU Medical in a research report on Wednesday, March 12th. Finally, Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $168.67.
Check Out Our Latest Stock Analysis on ICUI
Insider Buying and Selling at ICU Medical
In related news, CEO Vivek Jain sold 1,373 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 6.70% of the company's stock.
ICU Medical Price Performance
Shares of ICU Medical stock traded up $0.06 during midday trading on Tuesday, hitting $149.88. 238,271 shares of the company were exchanged, compared to its average volume of 256,802. The firm has a 50 day simple moving average of $155.91 and a 200-day simple moving average of $164.35. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a market cap of $3.67 billion, a P/E ratio of -32.80 and a beta of 0.73. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26.
ICU Medical Company Profile
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Featured Articles
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
